253428 Scope of Adverse Drug Reactions and Challenges

Monday, October 31, 2011: 2:30 PM

Donald Light, PhD , Psychiatry/Social and Behavioral Medicine, University of Medicine and Dentistry of New Jersey, School of Osteopathic Medicine, Princeton, NJ
This brief presentation will describe how adverse drug reactions have become a leading cause of hospitalization and death. Yet offsetting benefits are minimal because 85 percent new drugs are judged by independent panels to offer few advantages over existing ones.

The presentation will explain how the Risk Proliferation Syndrome maximizes the number of new drugs with few advantages but under-tested for risks of harm and then maximizes the number of people exposed to those risks.

Learning Areas:
Advocacy for health and health education
Protection of the public in relation to communicable diseases including prevention or control
Public health or related public policy
Social and behavioral sciences

Learning Objectives:
1. Describe the extent of adverse drug reactions in the United States 2. Explain how the Risk Proliferation Syndrome maximizes the number of people put at risk

Keywords: Epidemiology, Drug Safety

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: Ten years of policy research and publications
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.